0000766704false2023Q1December 31P1Yhttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#ReceivablesAndOtherAssetshttp://www.welltower.com/20230331#ReceivablesAndOtherAssetshttp://fasb.org/us-gaap/2022#RealEstateHeldforsalehttp://fasb.org/us-gaap/2022#RealEstateHeldforsalehttp://www.welltower.com/20230331#LeaseLiabilityhttp://www.welltower.com/20230331#LeaseLiabilityhttp://www.welltower.com/20230331#LeaseLiabilityhttp://www.welltower.com/20230331#LeaseLiabilityP3Y00007667042023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704well:GuaranteeNotesDue20284800Member2023-01-012023-03-310000766704well:GuaranteeNotesDue20344500Member2023-01-012023-03-3100007667042023-04-28xbrli:shares00007667042023-03-31iso4217:USD00007667042022-12-310000766704us-gaap:ManagementServiceMember2023-01-012023-03-310000766704us-gaap:ManagementServiceMember2022-01-012022-03-3100007667042022-01-012022-03-310000766704well:InterestRevenueMember2023-01-012023-03-310000766704well:InterestRevenueMember2022-01-012022-03-310000766704us-gaap:ProductAndServiceOtherMember2023-01-012023-03-310000766704us-gaap:ProductAndServiceOtherMember2022-01-012022-03-31iso4217:USDxbrli:shares0000766704us-gaap:CommonStockMember2022-12-310000766704us-gaap:AdditionalPaidInCapitalMember2022-12-310000766704us-gaap:TreasuryStockCommonMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-12-310000766704well:AccumulatedDistributionsMember2022-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000766704us-gaap:NoncontrollingInterestMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-01-012023-03-310000766704us-gaap:NoncontrollingInterestMember2023-01-012023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000766704well:AccumulatedDistributionsMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-03-310000766704us-gaap:TreasuryStockCommonMember2023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-03-310000766704well:AccumulatedDistributionsMember2023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000766704us-gaap:NoncontrollingInterestMember2023-03-310000766704us-gaap:CommonStockMember2021-12-310000766704us-gaap:AdditionalPaidInCapitalMember2021-12-310000766704us-gaap:TreasuryStockCommonMember2021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2021-12-310000766704well:AccumulatedDistributionsMember2021-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000766704us-gaap:NoncontrollingInterestMember2021-12-3100007667042021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-01-012022-03-310000766704us-gaap:NoncontrollingInterestMember2022-01-012022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-01-012022-03-310000766704us-gaap:TreasuryStockCommonMember2022-01-012022-03-310000766704well:AccumulatedDistributionsMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-03-310000766704us-gaap:TreasuryStockCommonMember2022-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-03-310000766704well:AccumulatedDistributionsMember2022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000766704us-gaap:NoncontrollingInterestMember2022-03-3100007667042022-03-310000766704well:WelltowerOPIncMember2023-01-012023-03-31xbrli:pure0000766704well:WelltowerOPIncMember2023-03-310000766704well:OtherInvestorsMemberwell:WelltowerOPIncMember2023-03-310000766704well:SeniorHousingOperatingMemberwell:COVID19Member2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberwell:COVID19Member2022-01-012022-03-310000766704well:SeniorHousingOperatingMember2023-03-310000766704well:TripleNetMember2023-03-310000766704well:OutpatientMedicalMember2023-03-310000766704well:SeniorHousingOperatingMember2022-03-310000766704well:TripleNetMember2022-03-310000766704well:OutpatientMedicalMember2022-03-310000766704well:SeniorHousingOperatingMember2023-01-012023-03-310000766704well:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMember2022-01-012022-03-310000766704well:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMember2022-01-012022-03-310000766704well:HolidayRetirementMember2022-04-01well:property00007667042022-04-012022-04-010000766704us-gaap:OtherIncomeMember2022-04-012022-06-300000766704us-gaap:LeasesAcquiredInPlaceMember2023-03-310000766704us-gaap:LeasesAcquiredInPlaceMember2022-12-310000766704us-gaap:AboveMarketLeasesMember2023-03-310000766704us-gaap:AboveMarketLeasesMember2022-12-310000766704well:LeaseCommissionsMember2023-03-310000766704well:LeaseCommissionsMember2022-12-310000766704us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2023-03-310000766704us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-03-310000766704us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2022-01-012022-03-310000766704srt:MinimumMember2023-01-012023-03-310000766704srt:MaximumMember2023-01-012023-03-310000766704us-gaap:CostOfSalesMember2023-01-012023-03-310000766704us-gaap:CostOfSalesMember2022-01-012022-03-310000766704us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-03-310000766704us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMember2023-03-310000766704us-gaap:OperatingSegmentsMember2022-12-310000766704us-gaap:CorporateNonSegmentMember2023-03-310000766704us-gaap:CorporateNonSegmentMember2022-12-310000766704well:OperatingSegmentsAndCorporateNonSegmentMember2023-03-310000766704well:OperatingSegmentsAndCorporateNonSegmentMember2022-12-310000766704us-gaap:MortgageReceivablesMember2023-03-310000766704us-gaap:MortgageReceivablesMember2022-12-310000766704well:OtherRealEstateLoansReceivablesMember2023-03-310000766704well:OtherRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:RealEstateLoanMember2023-03-310000766704us-gaap:RealEstateLoanMember2022-12-310000766704well:DeterioratedLoansMember2023-03-31well:loan0000766704well:CollectiveLoanPool1Member2023-03-310000766704well:CollectiveLoanPool2Member2023-03-310000766704well:CollectiveLoanPool3Member2023-03-310000766704well:CollectiveLoanPool4Member2023-03-310000766704well:CollectiveLoanPool5Member2023-03-310000766704well:CollectiveLoanPool6Member2023-03-310000766704us-gaap:RealEstateLoanMember2023-03-310000766704well:SeniorsHousingOperatingMembersrt:MinimumMember2023-03-310000766704well:SeniorsHousingOperatingMembersrt:MaximumMember2023-03-310000766704well:SeniorsHousingOperatingMember2023-03-310000766704well:SeniorsHousingOperatingMember2022-12-310000766704well:TripleNetMembersrt:MinimumMember2023-03-310000766704well:TripleNetMembersrt:MaximumMember2023-03-310000766704well:TripleNetMember2023-03-310000766704well:TripleNetMember2022-12-310000766704well:OutpatientMedicalMembersrt:MinimumMember2023-03-310000766704srt:MaximumMemberwell:OutpatientMedicalMember2023-03-310000766704well:OutpatientMedicalMember2023-03-310000766704well:OutpatientMedicalMember2022-12-310000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-03-31well:properties0000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:SunriseSeniorLivingMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:SunriseSeniorLivingMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:CogirManagementCorporationMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:CogirManagementCorporationMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:HCOneGroupMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:HCOneGroupMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:RemainingPortfolioMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:RemainingPortfolioMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704well:HCOneGroupMember2023-03-31iso4217:GBPwell:bank0000766704us-gaap:RevolvingCreditFacilityMember2023-03-310000766704well:TermCreditFacilityMember2023-03-310000766704well:TermCreditFacilityCADDenominatedMember2023-03-31iso4217:CAD0000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDue2026Member2023-03-310000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDue2025Member2023-03-31well:Term0000766704us-gaap:RevolvingCreditFacilityMember2023-01-012023-03-310000766704us-gaap:RevolvingCreditFacilityMemberwell:AccordionfeaturememberMember2023-03-310000766704well:TermCreditFacilityCADDenominatedMemberwell:AccordionfeaturememberMember2023-03-310000766704us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-03-310000766704us-gaap:CommercialPaperMembersrt:MaximumMember2023-01-012023-03-310000766704us-gaap:CommercialPaperMember2023-03-310000766704us-gaap:UnsecuredDebtMember2023-03-310000766704us-gaap:SecuredDebtMember2023-03-310000766704us-gaap:UnsecuredDebtMembersrt:MinimumMember2023-03-310000766704us-gaap:UnsecuredDebtMembersrt:MaximumMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:A295SeniorUnsecuredNotesDue2023Member2023-03-310000766704us-gaap:SecuredDebtMembersrt:MinimumMember2023-03-310000766704srt:MaximumMemberus-gaap:SecuredDebtMember2023-03-310000766704well:UnsecuredTermCreditFacilityMaturesJuly192023Memberus-gaap:UnsecuredDebtMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-03-31well:term0000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-01-012023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-03-310000766704well:UnsecuredTermCreditFacilityMaturesJuly192023Memberus-gaap:UnsecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-01-012023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-03-310000766704well:UkDebtDue2028Memberus-gaap:UnsecuredDebtMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:A450SeniorUnsecuredNotesDue2034Member2023-03-310000766704us-gaap:UnsecuredDebtMember2022-12-310000766704us-gaap:UnsecuredDebtMember2021-12-310000766704us-gaap:UnsecuredDebtMember2023-01-012023-03-310000766704us-gaap:UnsecuredDebtMember2022-01-012022-03-310000766704us-gaap:UnsecuredDebtMember2022-03-310000766704us-gaap:SecuredDebtMember2022-12-310000766704us-gaap:SecuredDebtMember2021-12-310000766704us-gaap:SecuredDebtMember2023-01-012023-03-310000766704us-gaap:SecuredDebtMember2022-01-012022-03-310000766704us-gaap:SecuredDebtMember2022-03-310000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2022-03-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000766704us-gaap:CashFlowHedgingMembercurrency:USDus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000766704us-gaap:CashFlowHedgingMembercurrency:USDus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000766704currency:USDus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2023-03-310000766704currency:USDus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2022-12-310000766704currency:USDus-gaap:NondesignatedMember2023-03-310000766704currency:USDus-gaap:NondesignatedMember2022-12-310000766704currency:CADus-gaap:NondesignatedMember2023-03-310000766704currency:CADus-gaap:NondesignatedMember2022-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-03-310000766704us-gaap:NondesignatedMember2023-01-012023-03-310000766704us-gaap:NondesignatedMember2022-01-012022-03-310000766704us-gaap:WarrantMember2023-01-012023-03-310000766704us-gaap:WarrantMember2022-01-012022-03-310000766704us-gaap:OtherComprehensiveIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704us-gaap:OtherComprehensiveIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-03-31well:obligation0000766704well:CapitalImprovementsMember2023-03-310000766704well:AtTheMarketProgramMember2022-04-300000766704well:AtTheMarketProgramMember2023-03-310000766704us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000766704us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000766704us-gaap:EmployeeStockOptionMember2022-01-012022-03-310000766704us-gaap:MortgagesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000766704us-gaap:MortgagesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-03-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-03-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:FairValueInputsLevel1Member2023-03-310000766704us-gaap:FairValueInputsLevel2Member2023-03-310000766704us-gaap:FairValueInputsLevel3Member2023-03-310000766704us-gaap:WarrantMember2022-12-310000766704us-gaap:WarrantMember2021-12-310000766704us-gaap:WarrantMember2023-01-012023-03-310000766704us-gaap:WarrantMember2022-01-012022-03-310000766704us-gaap:WarrantMember2023-03-310000766704us-gaap:WarrantMember2022-03-310000766704well:TerminalCapitalizationRateMember2023-03-31well:segment0000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2023-01-012023-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000766704us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberwell:InterestRevenueMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2023-01-012023-03-310000766704well:InterestRevenueMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-03-310000766704us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2023-03-310000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2022-01-012022-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2022-01-012022-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000766704us-gaap:CorporateNonSegmentMember2022-01-012022-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberwell:InterestRevenueMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2022-01-012022-03-310000766704well:InterestRevenueMemberus-gaap:CorporateNonSegmentMember2022-01-012022-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-03-310000766704us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2022-01-012022-03-310000766704country:US2023-01-012023-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:US2022-01-012022-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:GB2023-01-012023-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:GB2022-01-012022-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:CA2023-01-012023-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:CA2022-01-012022-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:USus-gaap:ManagementServiceMember2023-01-012023-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:USus-gaap:ManagementServiceMember2022-01-012022-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:GBus-gaap:ManagementServiceMember2023-01-012023-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:GBus-gaap:ManagementServiceMember2022-01-012022-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:CAus-gaap:ManagementServiceMember2023-01-012023-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:CAus-gaap:ManagementServiceMember2022-01-012022-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:US2023-03-310000766704country:USus-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704country:US2022-12-310000766704country:USus-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704country:GB2023-03-310000766704us-gaap:AssetsTotalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704country:GB2022-12-310000766704us-gaap:AssetsTotalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704country:CA2023-03-310000766704us-gaap:AssetsTotalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704country:CA2022-12-310000766704us-gaap:AssetsTotalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704us-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704us-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-03-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-12-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
   
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
or
   
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                      
Commission file number: 1-8923
WELLTOWER INC.
 
(Exact name of registrant as specified in its charter
Delaware
34-1096634
(State or other jurisdiction
of Incorporation)
(IRS Employer
Identification No.)
4500 Dorr StreetToledo,Ohio43615
(Address of principal executive office)(Zip Code)
(419) -247-2800
(Registrant’s telephone number, including area code)  
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $1.00 par value per shareWELLNew York Stock Exchange
Guarantee of 4.800% Notes due 2028 issued by Welltower OP LLCWELL/28New York Stock Exchange
Guarantee of 4.500% Notes due 2034 issued by Welltower OP LLCWELL/34New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 þ
 Accelerated filer
¨
 Non-accelerated filer
¨
 Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No  þ
As of April 28, 2023, Welltower Inc. had 497,031,161 shares of common stock outstanding.





TABLE OF CONTENTS
 
 
PART I. FINANCIAL INFORMATIONPage
  
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets
  
Consolidated Statements of Comprehensive Income
  
Consolidated Statements of Equity
  
Consolidated Statements of Cash Flows
  
Notes to Unaudited Consolidated Financial Statements
  
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  
Item 3. Quantitative and Qualitative Disclosures About Market Risk
  
Item 4. Controls and Procedures
  
PART II. OTHER INFORMATION 
  
Item 1. Legal Proceedings
  
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
  
Item 5. Other Information
  
Item 6. Exhibits
  
Signatures



PART I. FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEETS
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
March 31, 2023 (Unaudited)December 31, 2022 (Note)
Assets:  
  
Real estate investments:  
  
Real property owned:  
Land and land improvements  $4,324,541 $4,249,834 
Buildings and improvements  34,161,466 33,651,336 
Acquired lease intangibles  1,990,830 1,945,458 
Real property held for sale, net of accumulated depreciation  215,583 133,058 
Construction in progress  1,121,446 1,021,080 
Less accumulated depreciation and amortization  (8,417,151)(8,075,733)
Net real property owned  33,396,715 32,925,033 
Right of use assets, net322,896 323,942 
Real estate loans receivable, net of credit allowance  954,156 890,844 
Net real estate investments  34,673,767 34,139,819 
Other assets:  
Investments in unconsolidated entities  1,596,413 1,499,790 
Goodwill  68,321 68,321 
Cash and cash equivalents  571,902 631,681 
Restricted cash  66,894 90,611 
Straight-line rent receivable357,359 322,173 
Receivables and other assets  1,159,233 1,140,838 
Total other assets  3,820,122 3,753,414 
Total assets  
$38,493,889 $37,893,233 
Liabilities and equity  
Liabilities:  
Unsecured credit facility and commercial paper$ $ 
Senior unsecured notes  12,486,229 12,437,273 
Secured debt  2,474,837 2,110,815 
Lease liabilities415,169 415,824 
Accrued expenses and other liabilities  1,521,499 1,535,325 
Total liabilities  
16,897,734 16,499,237 
Redeemable noncontrolling interests  
392,195 384,443 
Equity:  
Common stock  497,928 491,919 
Capital in excess of par value  27,160,014 26,742,750 
Treasury stock  (112,925)(111,001)
Cumulative net income  8,830,623 8,804,950 
Cumulative dividends  (15,815,926)(15,514,097)
Accumulated other comprehensive income (loss)  (111,559)(119,707)
Total Welltower Inc. stockholders’ equity  20,448,155 20,294,814 
Noncontrolling interests  755,805 714,739 
Total equity  
21,203,960 21,009,553 
Total liabilities and equity  
$38,493,889 $37,893,233 
Note: The consolidated balance sheet at December 31, 2022 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

3


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands, except per share data) 
Three Months Ended
March 31,
 20232022
Revenues:  
Resident fees and services$1,131,685 $994,335 
Rental income  384,059 356,390 
Interest income36,405 38,994 
Other income8,580 5,985 
Total revenues1,560,729 1,395,704 
Expenses:
Property operating expenses957,753 853,669 
Depreciation and amortization339,112 304,088 
Interest expense144,403 121,696 
General and administrative expenses44,371 37,706 
Loss (gain) on derivatives and financial instruments, net930 2,578 
Loss (gain) on extinguishment of debt, net5 (12)
Provision for loan losses, net777 (804)
Impairment of assets12,629  
Other expenses22,745 26,069 
Total expenses1,522,725 1,344,990 
Income (loss) from continuing operations before income taxes and other items38,004 50,714 
Income tax (expense) benefit(3,045)(5,013)
Income (loss) from unconsolidated entities(7,071)(2,884)
Gain (loss) on real estate dispositions, net747 22,934 
Income (loss) from continuing operations28,635 65,751 
Net income (loss)28,635 65,751 
Less: Net income (loss) attributable to noncontrolling interests(1)
2,962 3,826 
Net income (loss) attributable to common stockholders$25,673 $61,925 
Weighted average number of common shares outstanding:
Basic492,061 447,379 
Diluted494,494 449,802 
Earnings per share:
Basic:
Income (loss) from continuing operations$0.06 $0.15 
Net income (loss) attributable to common stockholders$0.05 $0.14 
Diluted:
Income (loss) from continuing operations$0.06 $0.15 
Net income (loss) attributable to common stockholders(2)
$0.05 $0.14 
Dividends declared and paid per common share$0.61 $0.61 
(1) Includes amounts attributable to redeemable noncontrolling interests.
(2) Includes adjustment to the numerator for income (loss) attributable to OP Units and DownREIT Units.

4


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
 Three Months Ended
March 31,
 20232022
Net income (loss)$28,635 $65,751 
Other comprehensive income (loss):
Foreign currency translation gain (loss)80,765 (66,948)
Derivative and financial instruments designated as hedges gain (loss)(69,738)51,940 
Total other comprehensive income (loss)11,027 (15,008)
Total comprehensive income (loss)39,662 50,743 
Less: Total comprehensive income (loss) attributable
to noncontrolling interests(1)
5,841 5,974 
Total comprehensive income (loss) attributable to common stockholders$33,821 $44,769 
(1) Includes amounts attributable to redeemable noncontrolling interests.

5


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Three Months Ended March 31, 2023
Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2023$491,919 $26,742,750 $(111,001)$8,804,950 $(15,514,097)$(119,707)$714,739 $21,009,553 
Comprehensive income:
Net income (loss)   25,673   2,688 28,361 
Other comprehensive income (loss)     8,148 3,023 11,171 
Total comprehensive income       39,532 
Net change in noncontrolling interests (8,304)    29,648 21,344 
Adjustment to members' interest from change in ownership in Welltower OP (6,139)    6,139  
Redemption of OP Units and DownREIT Units272 17,515     (432)17,355 
Amounts related to stock incentive plans, net of forfeitures134 9,330 (1,924)    7,540 
Net proceeds from issuance of common stock5,603 404,862      410,465 
Dividends paid:
Common stock dividends    (301,829)  (301,829)
Balances at March 31, 2023$497,928 $27,160,014 $(112,925)$8,830,623 $(15,815,926)$(111,559)$755,805 $21,203,960 
 Three Months Ended March 31, 2022
 Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2022$448,605 $23,133,641 $(107,750)$8,663,736 $(14,380,915)$(121,316)$960,578 $18,596,579 
Comprehensive income:
Net income (loss)61,925 2,752 64,677 
Other comprehensive income (loss)(17,156)1,465 (15,691)
Total comprehensive income48,986 
Net change in noncontrolling interests(63,026)(128,305)(191,331)
Amounts related to stock incentive plans, net of forfeitures166 7,279 (4,768)2,677 
Net proceeds from issuance of common stock6,605 542,218 548,823 
Dividends paid:
Common stock dividends(273,668)(273,668)
Balances at March 31, 2022$455,376 $23,620,112 $(112,518)$8,725,661 $(14,654,583)$(138,472)$836,490 $18,732,066 

6


CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Three Months Ended
March 31,
 20232022
Operating activities:    
Net income  $28,635 $65,751 
Adjustments to reconcile net income to net cash provided from (used in) operating activities:  
Depreciation and amortization  
339,112 304,088 
Other amortization expenses  
9,792 5,592 
Provision for loan losses, net777 (804)
Impairment of assets  
12,629  
Stock-based compensation expense  
9,456 7,445 
Loss (gain) on derivatives and financial instruments, net  
930 2,578 
Loss (gain) on extinguishment of debt, net  
5 (12)
Loss (income) from unconsolidated entities
7,071 2,884 
Rental income less than (in excess of) cash received  
(36,827)(22,215)
Amortization related to above (below) market leases, net  
(82)(419)
Loss (gain) on real estate dispositions, net  
(747)(22,934)
Distributions by unconsolidated entities
3,418 6,982 
Increase (decrease) in accrued expenses and other liabilities  
(4,503)(23,416)
Decrease (increase) in receivables and other assets  
6,392 (1,000)
Net cash provided from (used in) operating activities  376,058 324,520 
 
Investing activities:  
Cash disbursed for acquisitions, net of cash acquired
(402,719)(601,410)
Cash disbursed for capital improvements to existing properties
(91,339)(90,229)
Cash disbursed for construction in progress
(226,226)(138,141)
Capitalized interest  
(10,335)(5,479)
Investment in loans receivable
(54,831)(39,201)
Principal collected on loans receivable  
15,592 89,207 
Other investments, net of payments  
(80,548)2,401 
Contributions to unconsolidated entities  
(112,822)(115,249)
Distributions by unconsolidated entities  
4,800 5,882 
Proceeds from (payments on) derivatives  
3,933 10,104 
Proceeds from sales of real property  
21,658 73,568 
Net cash provided from (used in) investing activities  (932,837)(808,547)
Financing activities:  
Net increase (decrease) under unsecured credit facility and commercial paper
 (24,967)
Net proceeds from issuance of senior unsecured notes 545,082 
Net proceeds from the issuance of secured debt  
362,900 5,385 
Payments on secured debt  
(39,573)(116,789)
Net proceeds from the issuance of common stock  
411,032 549,346 
Payments for deferred financing costs and prepayment penalties  
(6,444)(69)
Contributions by noncontrolling interests(1)
83,480 4,101 
Distributions to noncontrolling interests(1)
(35,664)(177,979)
Cash distributions to stockholders  
(300,195)(273,045)
Other financing activities
(5,066)(5,960)
Net cash provided from (used in) financing activities  470,470 505,105 
Effect of foreign currency translation on cash and cash equivalents and restricted cash2,813 (790)
Increase (decrease) in cash, cash equivalents and restricted cash  (83,496)20,288 
Cash, cash equivalents and restricted cash at beginning of period  722,292 346,755 
Cash, cash equivalents and restricted cash at end of period  $638,796 $367,043 
Supplemental cash flow information:
Interest paid$148,399 $123,012 
Income taxes paid (received), net325 631 
(1) Includes amounts attributable to redeemable noncontrolling interests.

7

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business
Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. We invest with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower Inc., a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (“U.S.”), Canada and the United Kingdom (“U.K.”), consisting of seniors housing and post-acute communities and outpatient medical properties. 
As of May 24, 2022, we are structured as an umbrella partnership REIT under which substantially all of our business is conducted through Welltower OP LLC, the day-to-day management of which is exclusively controlled by Welltower Inc. Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP. Welltower's weighted average ownership in Welltower OP was 99.735% for the three months ended March 31, 2023. As of March 31, 2023, Welltower owned 99.721% of the issued and outstanding units of Welltower OP, with other investors owning the remaining 0.279% of outstanding units. We adjust the noncontrolling members' interest at the end of each period to reflect their interest in the net assets of Welltower OP.
2. Accounting Policies and Related Matters
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023 are not necessarily an indication of the results that may be expected for the year ending December 31, 2023. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.
Impact of COVID-19 Pandemic & Government Grants
The extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants in the future is uncertain and cannot be predicted with confidence. We have received government grants under the CARES Act, as well as under similar programs in the U.K. and Canada, primarily to cover increased expenses and lost revenue during the COVID-19 pandemic. We recognized $4,136,000 and $5,760,000 during the three months ended March 31, 2023 and 2022, respectively. These grants represent a reduction to property operating expenses in our Consolidated Statements of Comprehensive Income. The amount of qualifying expenditures and lost revenue exceeded grant income recognized and we believe we have complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts are subject to recapture.
New Accounting Standards   
In March 2020, the FASB issued an amendment to the reference rate reform standard, which provides the option for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on contract modifications and hedge accounting. An example of such reform is the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. Entities that make this optional expedient election would not have to remeasure the contracts at the modification date or reassess the accounting treatment if certain criteria are met and would continue applying hedge accounting for relationships affected by reference rate reform. In December 2022, the FASB extended the date for which this guidance can be applied from December 31, 2022 to December 31, 2024. We continue to monitor developments related to the LIBOR transition and identification of an alternative, market-accepted rate.
3. Real Property Acquisitions and Development 
The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets and liabilities at cost on a relative fair value basis. Liabilities assumed and any associated noncontrolling interests are reflected at fair value. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services, termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income.
8

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our real property investment activity by segment for the periods presented (in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
Seniors Housing OperatingTriple-netOutpatient
Medical
TotalsSeniors Housing OperatingTriple-netOutpatient
Medical
Totals
Land and land improvements$2,517 $7,370 $60,527 $70,414 $43,897 $ $240 $44,137 
Buildings and improvements16,434 74,289 255,706 346,429 402,342 171 131,412 533,925 
Acquired lease intangibles865  39,090 39,955 31,366  16,978 48,344 
Right of use assets, net  927 927   3,852 3,852 
Total net real estate assets19,816 81,659 356,250 457,725 477,605 171 152,482 630,258 
Receivables and other assets234  358 592 1,630   1,630 
Total assets acquired20,050 81,659 356,608 458,317 479,235 171 152,482 631,888 
Secured debt(5,501) (40,953)(46,454)    
Lease liabilities  (953)(953)  (3,852)(3,852)
Accrued expenses and other liabilities(120) (8,071)(8,191)(4,154)  (4,154)
Total liabilities acquired(5,621) (49,977)(55,598)(4,154) (3,852)(8,006)
Noncontrolling interests (1)
    (20,348)(4) (20,352)
Non-cash acquisition related activity(2)
    (2,120)  (2,120)
Cash disbursed for acquisitions14,429 81,659 306,631 402,719 452,613 167 148,630 601,410 
Construction in progress additions131,944 4,995 101,609 238,548 113,407 20,756 9,642 143,805 
Less: Capitalized interest(7,950)(1,248)(1,137)(10,335)(4,179)(1,089)(211)(5,479)
Accruals (3)
2,303  (4,290)(1,987)(1,963) 1,778 (185)
Cash disbursed for construction in progress126,297 3,747 96,182 226,226 107,265 19,667 11,209 138,141 
Capital improvements to existing properties69,783 4,427 17,129 91,339 68,612 8,294 13,323 90,229 
Total cash invested in real property, net of cash acquired$210,509 $89,833 $419,942 $720,284 $628,490 $28,128 $173,162 $829,780 
(1) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests.
(2) Relates to the acquisition of assets recognized as investments in unconsolidated entities.
(3) Represents non-cash accruals for amounts to be paid in future periods for properties that converted, offset by amounts paid in the current period.
Effective on April 1, 2022, our leasehold interest relating to the master lease with National Health Investors, Inc. ("NHI") for 17 properties assumed in conjunction with the Holiday Retirement acquisition was terminated as a result of the transition or sale of the properties by NHI. The lease termination was part of an agreement to resolve outstanding litigation with NHI. In conjunction with the agreement, a wholly owned subsidiary and the lessee on the master lease agreed to release $6,883,000 of cash to the landlord, which represents the net cash flow generated from the properties since we assumed the leasehold interest. Additionally, in connection with the lease termination, during the three months ended June 30, 2022, we recognized $58,621,000 in other income on our Consolidated Statements of Comprehensive Income from the derecognition of the right of use asset and related lease liability.
Construction Activity 
The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
Development projects:
Seniors Housing Operating
$26,712 $73,458 
Outpatient Medical
9,351  
Total development projects
36,063 73,458 
Expansion projects
17,245  
Total construction in progress conversions$53,308 $73,458 


9

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
4. Real Estate Intangibles 
The following is a summary of our real estate intangibles, excluding those related to ground leases or classified as held for sale, as of the dates indicated (dollars in thousands):
 March 31, 2023December 31, 2022
Assets:
In place lease intangibles$1,846,945 $1,817,580 
Above market tenant leases66,354 57,203 
Lease commissions77,531 70,675 
Gross historical cost1,990,830 1,945,458 
Accumulated amortization(1,543,457)(1,484,048)
Net book value$447,373 $461,410 
Liabilities:
Below market tenant leases$82,084 $77,985 
Accumulated amortization(54,872)(52,701)
Net book value$27,212 $25,284 
The following is a summary of real estate intangible amortization income (expense) for the periods presented (in thousands):
Three Months Ended March 31,
20232022
Rental income related to (above)/below market tenant leases, net$45 $385 
Amortization related to in place lease intangibles and lease commissions(56,151)(47,994)
5. Dispositions, Real Property Held for Sale and Impairment
We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At March 31, 2023, five Seniors Housing Operating properties, seven Triple-net properties and one Outpatient Medical property with an aggregate real estate balance of $215,583,000 were classified as held for sale. In addition to the real property balances, lease liabilities of $66,530,000 and net other assets and (liabilities) of $6,095,000 are included in the Consolidated Balance Sheets related to the held for sale properties. Expected gross sales proceeds related to the held for sale properties are approximately $292,623,000.
During the three months ended March 31, 2023, we recorded $12,629,000 of impairment charges related to three Seniors Housing Operating properties classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell and one Seniors Housing Operating property classified as held for use for which the carrying value exceeded the estimated fair value. We did not record any impairment charges during the three months ended March 31, 2022.
The following is a summary of our real property disposition activity for the periods presented (in thousands):
 Three Months Ended
 March 31, 2023March 31, 2022
Real estate dispositions:
Seniors Housing Operating
$18,572 $ 
Triple-net
2,028 52,661 
Total dispositions
20,600 52,661 
Gain (loss) on real estate dispositions, net747 22,934 
Net other assets/(liabilities) disposed311 (2,027)
Proceeds from real estate dispositions$21,658 $73,568 
Operating results attributable to properties sold or classified as held for sale which do not meet the definition of discontinued operations are not reclassified on our Consolidated Statements of Comprehensive Income. We recognized income (loss) from continuing operations before income taxes and other items from properties sold or classified as held for sale as of March 31, 2023 of $(11,733,000) and $1,337,000 for the three month periods ended March 31, 2023 and 2022, respectively.


10

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
6. Leases
We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities.
The components of lease expense were as follows for the periods presented (in thousands):
Three Months Ended
 ClassificationMarch 31, 2023March 31, 2022
Operating lease cost: (1)
Real estate lease expenseProperty operating expenses$5,520 $5,816 
Non-real estate investment lease expenseGeneral and administrative expenses1,863 978 
Finance lease cost:
Amortization of leased assetsProperty operating expenses2,284 1,156 
Interest on lease liabilitiesInterest expense1,427 1,618 
Sublease incomeRental income(2,950)(2,715)
Total $8,144 $6,853 
(1) Includes short-term leases which are immaterial.
Supplemental balance sheet information related to leases in which we are the lessee is as follows (in thousands):
 ClassificationMarch 31, 2023December 31, 2022
Right of use assets:
Operating leases - real estateRight of use assets, net$287,275 $287,984 
Finance leases - real estateRight of use assets, net35,621 35,958 
Real estate right of use assets, net322,896 323,942 
Operating leases - non-real estate investmentsReceivables and other assets9,281 10,119 
Finance leases - held for sale (1)
Real property held for sale, net of accumulated depreciation115,359 116,453 
Total right of use assets, net$447,536 $450,514 
Lease liabilities:
Operating leases$301,915 $302,360